News
Media
PodcastsCase Based Peer PerspectivesClinical Forum InsightsInsightsInvestigator PerspectivesMedical World NewsPeer ExchangePeers & PerspectivesVideos
Conferences
Conference CoverageConference Listing
Publications
Contemporary OB/GYN® JournalDigital Supplements
More
CME/CE
Resources
Physician Fact SheetsInteractive ToolsSponsored MediaSponsored ResourcesSupplements and Featured Publications
About
Partnerships

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • About
  • Partnerships
  • Breast Health
  • COVID-19
  • Cervical Health
  • Contraception
  • Curbside Consults
  • Dermatology
  • Drug Pipeline News
  • Endometriosis
  • Genetic Testing
  • Gynecology
    • Gynecologic Oncology
  • Imaging
    • Fetal Imaging
    • Abnormal Obstetrical Ultrasound
    • MRI
    • Ultrasound
    • Women's Imaging
    • Breast Imaging
    • Women's Ultrasound
  • Infertility
  • LARC
  • Legally Speaking
  • Life Transitions
  • Malpractice
  • Menopause
  • Mental Health
  • Noninvasive Prenatal Testing
  • Obstetrics
  • Opinion
  • Osteoporosis
  • Pediatrics
  • Practice Management
  • Pregnancy and Birth
  • Sexual Health
  • Sexually Transmitted Infections
  • Surgery
  • Technology
  • Urology
  • Uterine Fibroids
  • Vulvovaginal Disease
  • Well Woman
Advertisement

Rhonda Amsel, PhD

Advertisement

Articles by Rhonda Amsel, PhD

The Treatment of Dyspareunia Resulting from Vulvar Vestibulitis

BySophie Bergeron, PhD,Yitzchak M. Binik, PhD,Samir Khalife, MD,Kelly Pagidas, MD,Howard I. Glazer, PhD,Marta Meana, PhD,Rhonda Amsel, PhD
October 24th 2011

A Randomized Comparison of Group Cognitive-behavioral Therapy, Surface Electromyographic Biofeedback, andVestibulectomy in the Treatment of Dyspareunia Resulting from Vulvar Vestibulitis

Advertisement

Latest Updated Articles

  • The Treatment of Dyspareunia Resulting from Vulvar Vestibulitis
    The Treatment of Dyspareunia Resulting from Vulvar Vestibulitis

    Published: October 24th 2011 | Updated:



Advertisement
Advertisement

Trending on Contemporary OB/GYN

1

Menopause associated with adverse mental health, reduced grey matter volume

2

American Academy of Pediatrics releases 2026 childhood immunization schedule

3

Rheumatoid arthritis deaths among postmenopausal women decline from 1999 to 2023

4

American Heart Association releases scientific statement for maternal stroke prevention during pregnancy, postpartum

5

Aviva to advance, announce new data for AVA-291 women's testosterone therapy

  • Advertise
  • Contact Us
  • Job Board
  • Terms of Use
  • Privacy Policy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us